BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15068827)

  • 1. Safety of ephedra: lessons learned.
    Soni MG; Carabin IG; Griffiths JC; Burdock GA
    Toxicol Lett; 2004 Apr; 150(1):97-110. PubMed ID: 15068827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric symptoms associated with ephedra use.
    Maglione M; Miotto K; Iguchi M; Hilton L; Shekelle P
    Expert Opin Drug Saf; 2005 Sep; 4(5):879-84. PubMed ID: 16111450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Feb; 69(28):6787-854. PubMed ID: 14968803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ephedrine and ephedra in weight loss products and other preparations].
    van der Hooft CS; Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA v. ephedra: is it time to lift the ban?
    Pyle KR
    Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
    [No Abstract]   [Full Text] [Related]  

  • 6. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
    Seamon MJ; Clauson KA
    J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ephedra ban: no shortage of reasons.
    Rados C
    FDA Consum; 2004; 38(2):6-7. PubMed ID: 15101356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Banning ephedra: good call, poor vision.
    Gordon JS
    Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
    [No Abstract]   [Full Text] [Related]  

  • 10. Ephedra: once a boon, now a bane.
    Scheindlin S
    Mol Interv; 2003 Oct; 3(7):358-60. PubMed ID: 14993455
    [No Abstract]   [Full Text] [Related]  

  • 11. Ephedra in perspective--a current review.
    Abourashed EA; El-Alfy AT; Khan IA; Walker L
    Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary supplements in weight reduction.
    Dwyer JT; Allison DB; Coates PM
    J Am Diet Assoc; 2005 May; 105(5 Suppl 1):S80-6. PubMed ID: 15867902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ephedra: heart dangers in disguise.
    Consum Rep; 2004 Jan; 69(1):22-3. PubMed ID: 14677546
    [No Abstract]   [Full Text] [Related]  

  • 14. Working to get ephedra banned.
    Consum Rep; 2003 Feb; 68(2):6. PubMed ID: 12516584
    [No Abstract]   [Full Text] [Related]  

  • 15. The Food and Drug Administration's actions on ephedra and androstenedione: understanding their potential impacts on the protections of the Dietary Supplement Health and Education Act.
    Siegner AW
    Food Drug Law J; 2004; 59(4):617-28. PubMed ID: 15880877
    [No Abstract]   [Full Text] [Related]  

  • 16. Addressing the potential risks associated with ephedra use: a review of recent efforts.
    Schulman S
    Public Health Rep; 2003; 118(6):487-92. PubMed ID: 14563905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ephedra and high fat dieting: a cause for concern! A case report.
    Fleming RM
    Angiology; 2007; 58(1):102-5. PubMed ID: 17351165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
    Maglione M; Miotto K; Iguchi M; Jungvig L; Morton SC; Shekelle PG
    Am J Psychiatry; 2005 Jan; 162(1):189-91. PubMed ID: 15625222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periconceptional use of weight loss products including ephedra and the association with birth defects.
    Bitsko RH; Reefhuis J; Louik C; Werler M; Feldkamp ML; Waller DK; Frias J; Honein MA;
    Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):553-62. PubMed ID: 18553492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.